On January 14th, Merck announced on January 12th local time that the US Food and Drug Administration (FDA) has approved Merck's PD-1 inhibitor Keytruda in combination with radiotherapy and chemothera ...

Pfizer ADC drug TIVDAK has been fully approved by the US FDA for the treatment of recurrent or metastatic cervical cancer. On May 6th, Zaiding Pharmaceuticals announced on its official WeChat account ...